Updated Date: 19-Jan-2026
Author: Abhishek Rastogi
Sources: IMARC Group
According to IMARC Group’s report titled “India Molecular Diagnostics Market Size, Share, Trends and Forecast by Product, Technology, Application, End User, and Region, 2026-2034″, the report offers a comprehensive analysis of the industry, including India molecular diagnostics market research report, share, growth and regional insights.
How Big is the India Molecular Diagnostics Industry ?
The India molecular diagnostics market size was valued at USD 1.4 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 2.8 Billion by 2034, exhibiting a CAGR of 7.79% from 2026-2034.
India Molecular Diagnostics Market Trends:
Precision medicine, infectious disease testing, and early disease detection grow as hospitals, laboratories, and homecare settings adopt them. Molecular diagnostic tests such as polymerase chain reaction (PCR), nucleic acid amplification tests (NAAT), and next-generation sequencing (NGS) widely diagnose infectious diseases, genetic disorders, and oncological disease because they are highly accurate. The COVID-19 pandemic fast-tracked the making of molecular testing infrastructure and workflows, accelerating molecular testing adoption within healthcare systems, routine diagnostics, and specialized healthcare settings. The introduction of automated platforms and point-of-care (POC) molecular platforms with their rapid test capabilities and applications for emergency medicine, infectious disease outbreaks and home healthcare are key market drivers.
Molecular diagnostics also converges with digital health technologies, cloud-based data analytics and laboratory information systems to improve data management, interoperate and decide clinically. Various drivers, along with the increasing emphasis on personalized medicine, are expected to augment the companion diagnostics and biomarker-based tests market. Furthermore, increasing partnerships among diagnostic device manufacturers, research organizations and hospitals to develop tests for a specific type of epidemiology in India is expected to drive the market. Consequently, this market is becoming both technologically advanced and clinically relevant, moving out of laboratories and into point-of-care settings.
India Molecular Diagnostics Market Scope and Growth Analysis:
Furthermore, the India molecular diagnostics market anticipates steady growth because healthcare facilities improved, the urban and rural population demands accurate diagnosis and diagnoses diseases early, and infectious diseases, cancer, genetic disorders, and lifestyle-related diseases increasingly prevail in hospitals, diagnostic chains, and specialty laboratories. Also, governments initiate development to surveil disease, advance programs that screen public health, and study genomics with the expectation of creating lucrative opportunities within the market.
Furthermore, improvements in healthcare financing and insurance reimbursement for advanced diagnostics are expected to improve market growth prospects. Trends in the market include large investments in laboratory facilities, workforce training, accreditation and quality control, to make tests more reliable and to increase confidence in the tests among patients, along with collaborations between global molecular diagnostics companies and local distributors to make tests more available and affordable, and less dependent on fragile supply chains. With advances in multiplex assays, liquid biopsy technologies, and integrated molecular platforms, India molecular diagnostics market is expected to continue on a growth path across clinical, research, and preventive healthcare settings.
Request Free Sample Report (Download Instantly): https://www.imarcgroup.com/india-molecular-diagnostics-market/requestsample
India Molecular Diagnostics Market Segmentation:
Analysis by Product:
- Reagents and Kits
- Instruments
- Software and Services
Analysis by Technology:
- Polymerase Chain Reactions (PCR)
- Hybridization
- DNA Sequencing
- Microarray
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Others
Analysis by Application:
- Infectious Diseases Diagnostics
- Oncology
- Genetic Testing
- Blood Screening
- Others
Analysis by End User:
- Hospitals
- Laboratories
- Others
Regional Analysis:
- North India
- West and Central India
- South India
- East and Northeast India
Competitive Landscape:
The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.
Other Key Points Covered in the Report:
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Market Dynamics
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
- Top Winning Strategies
- Recent Industry News
- Key Technological Trends & Development
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Contact Us:
IMARC Group
134 N 4th St., Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800, United States: +1-202071-6302